Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to pneumococcal vaccination in multiple myeloma.
Renaud L, Schraen S, Fouquet G, Guidez S, Demarquette H, Nudel M, Cayssials E, Bories C, Herbaux C, Systchenko T, Faucompré JL, Machet A, Sabirou F, Levy A, Bobin A, Richez V, Moya N, Gruchet C, Desmier D, van de Wyngaert Z, Carpentier B, Manier S, Facon T, Harding S, Leleu X. Renaud L, et al. Among authors: moya n. Cancer Med. 2019 Jul;8(8):3822-3830. doi: 10.1002/cam4.2253. Epub 2019 May 30. Cancer Med. 2019. PMID: 31145552 Free PMC article.
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.
Fouquet G, Snell KI, Guidez S, Schraen S, Boyle E, Renaud L, Desmier D, Machet A, Moya N, Systchenko T, Gruchet C, Decaux O, Arnulf B, Fohrer C, Richez V, Kolb B, Macro M, Karlin L, Royer B, Pegourie B, Hebraud B, Caillot D, Perrot A, Moreau P, Facon T, Avet-Loiseau H, Dejoie T, Hulin C, Harding S, Leleu X. Fouquet G, et al. Among authors: moya n. Leuk Lymphoma. 2018 Mar;59(3):583-589. doi: 10.1080/10428194.2017.1339876. Epub 2017 Jul 12. Leuk Lymphoma. 2018. PMID: 28697637
Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma.
Fouquet G, Guidez S, Richez V, Stoppa AM, Le Tourneau C, Macro M, Gruchet C, Bobin A, Moya N, Syshenko T, Sabirou F, Levy A, Franques P, Gardeney H, Karlin L, Benboubker L, Ouali M, Vedovato JC, Ferre P, Pavlyuk M, Attal M, Facon T, Leleu X. Fouquet G, et al. Among authors: moya n. Oncotarget. 2018 May 8;9(35):23890-23899. doi: 10.18632/oncotarget.25156. eCollection 2018 May 8. Oncotarget. 2018. PMID: 29844860 Free PMC article.
Carfilzomib weekly 20/56 mg/m2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
Richez V, Gruchet C, Guidez S, Fouquet G, Azais I, Durand G, Javaugue V, Brigaud A, Plasse F, Diolez J, Machet A, Moya N, Gardeney H, Franques P, Bobin A, Levy A, Sabirou F, Bonnin A, Dieval C, Primault S, Barrier J, Fleck E, Bouyier S, Daras C, Princet I, Bauwens D, Legros L, Fuzibet JG, Gil A, Bridoux F, Avet-Loiseau H, Leleu X. Richez V, et al. Among authors: moya n. Am J Hematol. 2019 Jan;94(1):E17-E20. doi: 10.1002/ajh.25327. Epub 2018 Nov 25. Am J Hematol. 2019. PMID: 30358902 Free article. No abstract available.
Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement.
Gallego Hernanz MP, Sorel N, Bouyer S, Desmier D, Chollet M, Maillard N, Brizard F, Moya N, Diaz JMT, Leleu X, Chomel JC. Gallego Hernanz MP, et al. Among authors: moya n. Leuk Lymphoma. 2020 Jul;61(7):1709-1713. doi: 10.1080/10428194.2020.1728751. Epub 2020 Feb 20. Leuk Lymphoma. 2020. PMID: 32077355 No abstract available.
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma.
Van de Wyngaert Z, Nerich V, Fouquet G, Chrétien ML, Caillot D, Azar N, Garderet L, Lenain P, Macro M, Bourhis JH, Belhocine R, Jaccard A, Karlin L, Bobin A, Moya N, Systchenko T, Gruchet C, Giraud C, Guidez S, Darras C, Princet I, Touzeau C, Moreau P, Hulin C, Deconinck E, Limat S, Leleu X; IFM (Intergroupe Français du Myélome – IFM 2014-05). Van de Wyngaert Z, et al. Among authors: moya n. Bone Marrow Transplant. 2020 Dec;55(12):2254-2260. doi: 10.1038/s41409-020-0940-3. Epub 2020 May 23. Bone Marrow Transplant. 2020. PMID: 32447348
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
Bobin A, Liuu E, Moya N, Gruchet C, Sabirou F, Lévy A, Gardeney H, Nsiala L, Cailly L, Guidez S, Tomowiak C, Systchenko T, Javaugue V, Durand G, Leleu X, Puyade M. Bobin A, et al. Among authors: moya n. Cancers (Basel). 2020 Oct 8;12(10):2885. doi: 10.3390/cancers12102885. Cancers (Basel). 2020. PMID: 33050025 Free PMC article. Review.
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients.
Gardeney H, Bobin A, Gruchet C, Sabirou F, Lévy A, Nsiala L, Cailly L, Tomowiak C, Torregrosa J, Moya N, Hulin C, Leleu X, Guidez S. Gardeney H, et al. Among authors: moya n. J Clin Med. 2020 Nov 4;9(11):3554. doi: 10.3390/jcm9113554. J Clin Med. 2020. PMID: 33158277 Free PMC article. Review.
Waldenström macroglobulinemia and relationship to immune deficiency.
Levy A, Guidez S, Debiais C, Princet I, Bouyer S, Dindinaud E, Delwail V, Systchenko T, Moya N, Gruchet C, Sabirou F, Bobin A, Gardeney H, Nsiala L, Cailly L, Olivier G, Motard C, Fleck E, Corby A, Roul C, Denis G, Dieval C, Leleu X, Tomowiak C. Levy A, et al. Among authors: moya n. Leuk Lymphoma. 2021 Nov;62(11):2665-2670. doi: 10.1080/10428194.2021.1907379. Epub 2021 Jun 4. Leuk Lymphoma. 2021. PMID: 34085595 Review.
Smoldering multiple myeloma: biology, clinical manifestations and management.
Nsiala L, Bobin A, Levy A, Gruchet C, Sabirou F, Gardeney H, Cailly L, Manier S, Moya N, Tomowiak C, Guidez S, Leleu X, Decaux O. Nsiala L, et al. Among authors: moya n. Leuk Lymphoma. 2022 Mar;63(3):518-529. doi: 10.1080/10428194.2021.1992615. Epub 2021 Oct 21. Leuk Lymphoma. 2022. PMID: 34672244
50 results